Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1995 Jul;57(1):22–33.

Spectrum of small mutations in the dystrophin coding region.

T W Prior 1, C Bartolo 1, D K Pearl 1, A C Papp 1, P J Snyder 1, M S Sedra 1, A H Burghes 1, J R Mendell 1
PMCID: PMC1801231  PMID: 7611292

Abstract

Duchenne and Becker muscular dystrophies (DMD and BMD) are caused by defects in the dystrophin gene. About two-thirds of the affected patients have large deletions or duplications, which occur in the 5' and central portion of the gene. The nondeletion/duplication cases are most likely the result of smaller mutations that cannot be identified by current diagnostic screening strategies. We screened approximately 80% of the dystrophin coding sequence for small mutations in 158 patients without deletions or duplications and identified 29 mutations. The study indicates that many of the DMD and the majority of the BMD small mutations lie in noncoding regions of the gene. All of the mutations identified were unique to single patients, and most of the mutations resulted in protein truncation. We did not find a clustering of small mutations similar to the deletion distribution but found > 40% of the small mutations 3' of exon 55. The extent of protein truncation caused by the 3' mutations did not determine the phenotype, since even the exon 76 nonsense mutation resulted in the severe DMD phenotype. Our study confirms that the dystrophin gene is subject to a high rate of mutation in CpG sequences. As a consequence of not finding any hotspots or prevalent small mutations, we conclude that it is presently not possible to perform direct carrier and prenatal diagnostics for many families without deletions or duplications.

Full text

PDF
22

Images in this article

27Figure 2
on p.27

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbs S., Roberts R. G., Mathew C. G., Bentley D. R., Bobrow M. Accurate assessment of intragenic recombination frequency within the Duchenne muscular dystrophy gene. Genomics. 1990 Aug;7(4):602–606. doi: 10.1016/0888-7543(90)90205-9. [DOI] [PubMed] [Google Scholar]
  2. Ahn A. H., Kunkel L. M. Syntrophin binds to an alternatively spliced exon of dystrophin. J Cell Biol. 1995 Feb;128(3):363–371. doi: 10.1083/jcb.128.3.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Akalin N., Zietkiewicz E., Makałowski W., Labuda D. Are CpG sites mutation hot spots in the dystrophin gene? Hum Mol Genet. 1994 Aug;3(8):1425–1426. doi: 10.1093/hmg/3.8.1425. [DOI] [PubMed] [Google Scholar]
  4. Arahata K., Beggs A. H., Honda H., Ito S., Ishiura S., Tsukahara T., Ishiguro T., Eguchi C., Orimo S., Arikawa E. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy. J Neurol Sci. 1991 Feb;101(2):148–156. doi: 10.1016/0022-510x(91)90039-a. [DOI] [PubMed] [Google Scholar]
  5. Baserga S. J., Benz E. J., Jr Beta-globin nonsense mutation: deficient accumulation of mRNA occurs despite normal cytoplasmic stability. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2935–2939. doi: 10.1073/pnas.89.7.2935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bebchuk K. G., Bulman D. E., D'Souza V. N., Worton R. G., Ray P. N. Genomic organization of exons 22 to 25 of the dystrophin gene. Hum Mol Genet. 1993 May;2(5):593–594. doi: 10.1093/hmg/2.5.593. [DOI] [PubMed] [Google Scholar]
  7. Beggs A. H., Koenig M., Boyce F. M., Kunkel L. M. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet. 1990 Nov;86(1):45–48. doi: 10.1007/BF00205170. [DOI] [PubMed] [Google Scholar]
  8. Beggs A. H., Kunkel L. M. A polymorphic CACA repeat in the 3' untranslated region of dystrophin. Nucleic Acids Res. 1990 Apr 11;18(7):1931–1931. doi: 10.1093/nar/18.7.1931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Belgrader P., Cheng J., Maquat L. E. Evidence to implicate translation by ribosomes in the mechanism by which nonsense codons reduce the nuclear level of human triosephosphate isomerase mRNA. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):482–486. doi: 10.1073/pnas.90.2.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bies R. D., Caskey C. T., Fenwick R. An intact cysteine-rich domain is required for dystrophin function. J Clin Invest. 1992 Aug;90(2):666–672. doi: 10.1172/JCI115909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bulman D. E., Gangopadhyay S. B., Bebchuck K. G., Worton R. G., Ray P. N. Point mutation in the human dystrophin gene: identification through western blot analysis. Genomics. 1991 Jun;10(2):457–460. doi: 10.1016/0888-7543(91)90332-9. [DOI] [PubMed] [Google Scholar]
  12. Bulman D. E., Murphy E. G., Zubrzycka-Gaarn E. E., Worton R. G., Ray P. N. Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin. Am J Hum Genet. 1991 Feb;48(2):295–304. [PMC free article] [PubMed] [Google Scholar]
  13. Burrow K. L., Coovert D. D., Klein C. J., Bulman D. E., Kissel J. T., Rammohan K. W., Burghes A. H., Mendell J. R. Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group. Neurology. 1991 May;41(5):661–666. doi: 10.1212/wnl.41.5.661. [DOI] [PubMed] [Google Scholar]
  14. Campbell K. P., Kahl S. D. Association of dystrophin and an integral membrane glycoprotein. Nature. 1989 Mar 16;338(6212):259–262. doi: 10.1038/338259a0. [DOI] [PubMed] [Google Scholar]
  15. Chamberlain J. S., Gibbs R. A., Ranier J. E., Nguyen P. N., Caskey C. T. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988 Dec 9;16(23):11141–11156. doi: 10.1093/nar/16.23.11141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Clemens P. R., Fenwick R. G., Chamberlain J. S., Gibbs R. A., de Andrade M., Chakraborty R., Caskey C. T. Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. Am J Hum Genet. 1991 Nov;49(5):951–960. [PMC free article] [PubMed] [Google Scholar]
  17. Darras B. T., Blattner P., Harper J. F., Spiro A. J., Alter S., Francke U. Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations. Am J Hum Genet. 1988 Nov;43(5):620–629. [PMC free article] [PubMed] [Google Scholar]
  18. Dennis J. A., Healy P. J., Beaudet A. L., O'Brien W. E. Molecular definition of bovine argininosuccinate synthetase deficiency. Proc Natl Acad Sci U S A. 1989 Oct;86(20):7947–7951. doi: 10.1073/pnas.86.20.7947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ervasti J. M., Campbell K. P. Membrane organization of the dystrophin-glycoprotein complex. Cell. 1991 Sep 20;66(6):1121–1131. doi: 10.1016/0092-8674(91)90035-w. [DOI] [PubMed] [Google Scholar]
  20. Feener C. A., Boyce F. M., Kunkel L. M. Rapid detection of CA polymorphisms in cloned DNA: application to the 5' region of the dystrophin gene. Am J Hum Genet. 1991 Mar;48(3):621–627. [PMC free article] [PubMed] [Google Scholar]
  21. Forrest S. M., Cross G. S., Flint T., Speer A., Robson K. J., Davies K. E. Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies. Genomics. 1988 Feb;2(2):109–114. doi: 10.1016/0888-7543(88)90091-2. [DOI] [PubMed] [Google Scholar]
  22. Gillard E. F., Chamberlain J. S., Murphy E. G., Duff C. L., Smith B., Burghes A. H., Thompson M. W., Sutherland J., Oss I., Bodrug S. E. Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet. 1989 Oct;45(4):507–520. [PMC free article] [PubMed] [Google Scholar]
  23. Grimm T., Meng G., Liechti-Gallati S., Bettecken T., Müller C. R., Müller B. On the origin of deletions and point mutations in Duchenne muscular dystrophy: most deletions arise in oogenesis and most point mutations result from events in spermatogenesis. J Med Genet. 1994 Mar;31(3):183–186. doi: 10.1136/jmg.31.3.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hagiwara Y., Nishio H., Kitoh Y., Takeshima Y., Narita N., Wada H., Yokoyama M., Nakamura H., Matsuo M. A novel point mutation (G-1 to T) in a 5' splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy. Am J Hum Genet. 1994 Jan;54(1):53–61. [PMC free article] [PubMed] [Google Scholar]
  25. Hamosh A., Trapnell B. C., Zeitlin P. L., Montrose-Rafizadeh C., Rosenstein B. J., Crystal R. G., Cutting G. R. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. J Clin Invest. 1991 Dec;88(6):1880–1885. doi: 10.1172/JCI115510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Helliwell T. R., Ellis J. M., Mountford R. C., Appleton R. E., Morris G. E. A truncated dystrophin lacking the C-terminal domains is localized at the muscle membrane. Am J Hum Genet. 1992 Mar;50(3):508–514. [PMC free article] [PubMed] [Google Scholar]
  27. Hoffman E. P., Garcia C. A., Chamberlain J. S., Angelini C., Lupski J. R., Fenwick R. Is the carboxyl-terminus of dystrophin required for membrane association? A novel, severe case of Duchenne muscular dystrophy. Ann Neurol. 1991 Oct;30(4):605–610. doi: 10.1002/ana.410300414. [DOI] [PubMed] [Google Scholar]
  28. Hu X. Y., Ray P. N., Murphy E. G., Thompson M. W., Worton R. G. Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet. 1990 Apr;46(4):682–695. [PMC free article] [PubMed] [Google Scholar]
  29. Kilimann M. W., Pizzuti A., Grompe M., Caskey C. T. Point mutations and polymorphisms in the human dystrophin gene identified in genomic DNA sequences amplified by multiplex PCR. Hum Genet. 1992 May;89(3):253–258. doi: 10.1007/BF00220535. [DOI] [PubMed] [Google Scholar]
  30. Klein C. J., Coovert D. D., Bulman D. E., Ray P. N., Mendell J. R., Burghes A. H. Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet. 1992 May;50(5):950–959. [PMC free article] [PubMed] [Google Scholar]
  31. Koenig M., Beggs A. H., Moyer M., Scherpf S., Heindrich K., Bettecken T., Meng G., Müller C. R., Lindlöf M., Kaariainen H. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet. 1989 Oct;45(4):498–506. [PMC free article] [PubMed] [Google Scholar]
  32. Koenig M., Monaco A. P., Kunkel L. M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988 Apr 22;53(2):219–228. doi: 10.1016/0092-8674(88)90383-2. [DOI] [PubMed] [Google Scholar]
  33. Lenk U., Hanke R., Thiele H., Speer A. Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients. Hum Mol Genet. 1993 Nov;2(11):1877–1881. doi: 10.1093/hmg/2.11.1877. [DOI] [PubMed] [Google Scholar]
  34. Malhotra S. B., Hart K. A., Klamut H. J., Thomas N. S., Bodrug S. E., Burghes A. H., Bobrow M., Harper P. S., Thompson M. W., Ray P. N. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science. 1988 Nov 4;242(4879):755–759. doi: 10.1126/science.3055295. [DOI] [PubMed] [Google Scholar]
  35. Mashima Y., Murakami A., Weleber R. G., Kennaway N. G., Clarke L., Shiono T., Inana G. Nonsense-codon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy. Am J Hum Genet. 1992 Jul;51(1):81–91. [PMC free article] [PubMed] [Google Scholar]
  36. Matsuo M., Masumura T., Nakajima T., Kitoh Y., Takumi T., Nishio H., Koga J., Nakamura H. A very small frame-shifting deletion within exon 19 of the Duchenne muscular dystrophy gene. Biochem Biophys Res Commun. 1990 Jul 31;170(2):963–967. doi: 10.1016/0006-291x(90)92185-3. [DOI] [PubMed] [Google Scholar]
  37. McCabe E. R., Towbin J., Chamberlain J., Baumbach L., Witkowski J., van Ommen G. J., Koenig M., Kunkel L. M., Seltzer W. K. Complementary DNA probes for the Duchenne muscular dystrophy locus demonstrate a previously undetectable deletion in a patient with dystrophic myopathy, glycerol kinase deficiency, and congenital adrenal hypoplasia. J Clin Invest. 1989 Jan;83(1):95–99. doi: 10.1172/JCI113890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Monaco A. P., Bertelson C. J., Liechti-Gallati S., Moser H., Kunkel L. M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988 Jan;2(1):90–95. doi: 10.1016/0888-7543(88)90113-9. [DOI] [PubMed] [Google Scholar]
  39. Nigro V., Nigro G., Esposito M. G., Comi L. I., Molinari A. M., Puca G. A., Politano L. Novel small mutations along the DMD/BMD gene associated with different phenotypes. Hum Mol Genet. 1994 Oct;3(10):1907–1908. doi: 10.1093/hmg/3.10.1907. [DOI] [PubMed] [Google Scholar]
  40. Nigro V., Politano L., Nigro G., Romano S. C., Molinari A. M., Puca G. A. Detection of a nonsense mutation in the dystrophin gene by multiple SSCP. Hum Mol Genet. 1992 Oct;1(7):517–520. doi: 10.1093/hmg/1.7.517. [DOI] [PubMed] [Google Scholar]
  41. Oudet C., Heilig R., Hanauer A., Mandel J. L. Nonradioactive assay for new microsatellite polymorphisms at the 5' end of the dystrophin gene, and estimation of intragenic recombination. Am J Hum Genet. 1991 Aug;49(2):311–319. [PMC free article] [PubMed] [Google Scholar]
  42. Oudet C., Heilig R., Mandel J. L. An informative polymorphism detectable by polymerase chain reaction at the 3' end of the dystrophin gene. Hum Genet. 1990 Feb;84(3):283–285. doi: 10.1007/BF00200576. [DOI] [PubMed] [Google Scholar]
  43. Powell J. F., Fodor F. H., Cockburn D. J., Monaco A. P., Craig I. W. A dinucleotide repeat polymorphism at the DMD locus. Nucleic Acids Res. 1991 Mar 11;19(5):1159–1159. doi: 10.1093/nar/19.5.1159-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Prior T. W., Bartolo C., Papp A. C., Snyder P. J., Sedra M. S., Burghes A. H., Mendell J. R. Identification of a missense mutation, single base deletion and a polymorphism in the dystrophin exon 16. Hum Mol Genet. 1994 Jul;3(7):1173–1174. doi: 10.1093/hmg/3.7.1173. [DOI] [PubMed] [Google Scholar]
  45. Prior T. W., Papp A. C., Snyder P. J., Burghes A. H., Bartolo C., Sedra M. S., Western L. M., Mendell J. R. A missense mutation in the dystrophin gene in a Duchenne muscular dystrophy patient. Nat Genet. 1993 Aug;4(4):357–360. doi: 10.1038/ng0893-357. [DOI] [PubMed] [Google Scholar]
  46. Prior T. W., Papp A. C., Snyder P. J., Burghes A. H., Sedra M. S., Western L. M., Bartolo C., Mendell J. R. Exon 44 nonsense mutation in two-Duchenne muscular dystrophy brothers detected by heteroduplex analysis. Hum Mutat. 1993;2(3):192–195. doi: 10.1002/humu.1380020307. [DOI] [PubMed] [Google Scholar]
  47. Rafael J. A., Sunada Y., Cole N. M., Campbell K. P., Faulkner J. A., Chamberlain J. S. Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform. Hum Mol Genet. 1994 Oct;3(10):1725–1733. doi: 10.1093/hmg/3.10.1725. [DOI] [PubMed] [Google Scholar]
  48. Roberts R. G., Bobrow M., Bentley D. R. Point mutations in the dystrophin gene. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2331–2335. doi: 10.1073/pnas.89.6.2331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Roberts R. G., Coffey A. J., Bobrow M., Bentley D. R. Determination of the exon structure of the distal portion of the dystrophin gene by vectorette PCR. Genomics. 1992 Aug;13(4):942–950. doi: 10.1016/0888-7543(92)90005-d. [DOI] [PubMed] [Google Scholar]
  50. Roberts R. G., Gardner R. J., Bobrow M. Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations. Hum Mutat. 1994;4(1):1–11. doi: 10.1002/humu.1380040102. [DOI] [PubMed] [Google Scholar]
  51. Roberts R. G., Passos-Bueno M. R., Bobrow M., Vainzof M., Zatz M. Point mutation in a Becker muscular dystrophy patient. Hum Mol Genet. 1993 Jan;2(1):75–77. doi: 10.1093/hmg/2.1.75. [DOI] [PubMed] [Google Scholar]
  52. Récan D., Chafey P., Leturcq F., Hugnot J. P., Vincent N., Tomé F., Collin H., Simon D., Czernichow P., Nicholson L. V. Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization? J Clin Invest. 1992 Feb;89(2):712–716. doi: 10.1172/JCI115640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Saad F. A., Busque C., Vitiello L., Danieli G. A. DXS997 localized to intron 48 of dystrophin. Hum Mol Genet. 1993 Dec;2(12):2199–2199. doi: 10.1093/hmg/2.12.2199. [DOI] [PubMed] [Google Scholar]
  54. Saad F. A., Vita G., Mora M., Morandi L., Vitiello L., Oliviero S., Danieli G. A. A novel nonsense mutation in the human dystrophin gene. Hum Mutat. 1993;2(4):314–316. doi: 10.1002/humu.1380020413. [DOI] [PubMed] [Google Scholar]
  55. Saad F. A., Vitiello L., Merlini L., Mostacciuolo M. L., Oliviero S., Danieli G. A. A 3' consensus splice mutation in the human dystrophin gene detected by a screening for intra-exonic deletions. Hum Mol Genet. 1992 Aug;1(5):345–346. doi: 10.1093/hmg/1.5.345. [DOI] [PubMed] [Google Scholar]
  56. Soto D., Sukumar S. Improved detection of mutations in the p53 gene in human tumors as single-stranded conformation polymorphs and double-stranded heteroduplex DNA. PCR Methods Appl. 1992 Aug;2(1):96–98. doi: 10.1101/gr.2.1.96. [DOI] [PubMed] [Google Scholar]
  57. Suzuki A., Yoshida M., Ozawa E. Mammalian alpha 1- and beta 1-syntrophin bind to the alternative splice-prone region of the dystrophin COOH terminus. J Cell Biol. 1995 Feb;128(3):373–381. doi: 10.1083/jcb.128.3.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Tsukamoto H., Inui K., Matsuoka T., Yanagihara I., Fukushima H., Okada S. One base deletion in the cysteine-rich domain of the dystrophin gene in Duchenne muscular dystrophy patients. Hum Mol Genet. 1994 Jun;3(6):995–996. doi: 10.1093/hmg/3.6.995. [DOI] [PubMed] [Google Scholar]
  59. Urlaub G., Mitchell P. J., Ciudad C. J., Chasin L. A. Nonsense mutations in the dihydrofolate reductase gene affect RNA processing. Mol Cell Biol. 1989 Jul;9(7):2868–2880. doi: 10.1128/mcb.9.7.2868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. White M. B., Carvalho M., Derse D., O'Brien S. J., Dean M. Detecting single base substitutions as heteroduplex polymorphisms. Genomics. 1992 Feb;12(2):301–306. doi: 10.1016/0888-7543(92)90377-5. [DOI] [PubMed] [Google Scholar]
  61. Wilton S. D., Chandler D. C., Kakulas B. A., Laing N. G. Identification of a point mutation and germinal mosaicism in a Duchenne muscular dystrophy family. Hum Mutat. 1994;3(2):133–140. doi: 10.1002/humu.1380030208. [DOI] [PubMed] [Google Scholar]
  62. Winnard A. V., Jia-Hsu Y., Gibbs R. A., Mendell J. R., Burghes A. H. Identification of a 2 base pair nonsense mutation causing a cryptic splice site in a DMD patient. Hum Mol Genet. 1992 Nov;1(8):645–646. doi: 10.1093/hmg/1.8.645. [DOI] [PubMed] [Google Scholar]
  63. Yoshida M., Ozawa E. Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem. 1990 Nov;108(5):748–752. doi: 10.1093/oxfordjournals.jbchem.a123276. [DOI] [PubMed] [Google Scholar]
  64. Youssoufian H., Kazazian H. H., Jr, Phillips D. G., Aronis S., Tsiftis G., Brown V. A., Antonarakis S. E. Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots. 1986 Nov 27-Dec 3Nature. 324(6095):380–382. doi: 10.1038/324380a0. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES